Achaogen
About Us
Company Overview
Our Culture
Management Team
Board of Directors
Scientific Advisory Board
Our Focus
Overview
MDR Gram-Negative Infections
Our Science
Pipeline
Pipeline Overview
Plazomicin
C-Scape
Monoclonal Antibody Program
Additional Gram-Negative Programs
Scientific Publications
Investors
Investor Overview
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Contact Us
Careers
Overview
Values
Benefits
Positions Available
Postdoctoral Program
Fellowship
Contact Us
Contact Information
Medical Information
About Us
/
Company Overview
Our Culture
Management Team
Board of Directors
Scientific Advisory Board
Our Focus
/
Overview
MDR Gram-Negative Infections
Our Science
Pipeline
/
Pipeline Overview
Plazomicin
C-Scape
Monoclonal Antibody Program
Additional Gram-Negative Programs
Scientific Publications
Investors
/
Investor Overview
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Contact Us
Careers
/
Overview
Values
Benefits
Positions Available
Postdoctoral Program
Fellowship
Contact Us
/
Contact Information
Medical Information
/
Media
About Us
/
Company Overview
Our Culture
Management Team
Board of Directors
Scientific Advisory Board
Our Focus
/
Overview
MDR Gram-Negative Infections
Our Science
Pipeline
/
Pipeline Overview
Plazomicin
C-Scape
Monoclonal Antibody Program
Additional Gram-Negative Programs
Scientific Publications
Investors
/
Investor Overview
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Contact Us
Careers
/
Overview
Values
Benefits
Positions Available
Postdoctoral Program
Fellowship
Contact Us
/
Contact Information
Medical Information
/
Media Archive
Press Releases
Scientific Publications
See more press releases
Media
Activity of Plazomicin and Comparator Agents Tested against Contemporary Clinical Isolates Collected Worldwide
about 6 days ago
A Multi-Site Study Comparing a Commercially Prepared Dried MIC Susceptibility System to the CLSI/ISO Broth Microdilution Method for Plazomicin using Non- Fastidious Gram-Negative Organisms
about 6 days ago
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses to Support Plazomicin Dose Selection and Recommendations for Interpretive Criteria for In Vitro Susceptibility Testing for Enterobacteriaceae
about 6 days ago
See more scientific publications
